MECP2 genomic structure and function: Insights from ENCODE

Nucleic Acids Research

Volumn 36, Issue 19, 2008, Pages 6035-6047

  Singh, Jasmine ^a,b   Saxena, Alka ^a   Christodoulou, John ^c   Ravine, David ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; RNA; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; EXON; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENE STRUCTURE; GENETIC VARIABILITY; GENOME ANALYSIS; GENOME SIZE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; X CHROMOSOME;

GENOME, HUMAN; HUMANS; METHYL-CPG-BINDING PROTEIN 2; REGULATORY ELEMENTS, TRANSCRIPTIONAL;

EID: 56049095959     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn591     Document Type: Article

References (100)

1. Mattick,J.S. and Makunin,I.V. (2006) Non-coding RNA. Hum. Mol. Genet., 15 (Spec No. 1), R17-R29.2.
2. The ENCODE Project Consortium. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
3. Gerstein,M.B., Bruce,C., Rozowsky,J.S., Zheng,D., Du,J., Korbel,J.O., Emanuelsson,O., Zhang,Z.D., Weissman,S. and Snyder,M. (2007) What is a gene, post-ENCODE? History and updated definition. Genome Res., 17, 669-681.
4. Gingeras,T.R. (2007) Origin of phenotypes: Genes and transcripts. Genome Res., 17, 682-690.
5. Johannsen,W. (1909) Elemente der exakten erblichkeitslehre: Deutsche Wesentlich erweiterte ausgabe in fünfundzwanzig vorlesuengen.G. Fisher Jena.
6. Morgan,T.H., Sturtevant,A.H., Muller,H.J. and Bridges,C.B. (1915) The Mechanism of Mendelian Heredity. New York, Holt Rinehart & Winston Holt Rinehart & Winston, New York.
7. Beadle,G.W. and Tatum,E.L. (1941) Genetic control of biochemical reactions in neurospora. Proc. Natl Acad. Sci. USA, 27, 499-506.
8. Kapranov,P., Willingham,A.T. and Gingeras,T.R. (2007) Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet., 8, 413-423.
9. Cheng,J., Kapranov,P., Drenkow,J., Dike,S., Brubaker,S., Patel,S., Long,J., Stern,D., Tammana,H., Helt,G. et al. (2005) Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science, 308, 1149-1154.
10. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin,K.M., Pringle, T.H., Zahler,A.M. and Haussler,D. (2002) The human genome browser at UCSC. Genome Res., 12, 996-1006.
11. Tennyson, C.N., Klamut,H.J. and Worton,R.G. (1995) The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet., 9, 184-190.
12. Reichwald,K., Thiesen,J., Wiehe,T., Weitzel,J., Poustka,W.A., Rosenthal,A., Platzer,M., Stratling,W.H. and Kioschis,P. (2000) Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm. Genome, 11, 182-190.
13. Adler,D.A., Quaderi,N.A., Brown,S.D., Chapman, V.M., Moore,J., Tate,P. and Disteche,C.M. (1995) The X-linked methylated DNA binding protein, Mecp2, is subject to X inactivation in the mouse. Mamm. Genome, 6, 491-492.
14. D'Esposito,M., Quaderi,N.A., Ciccodicola,A., Bruni,P., Esposito,T., D'Urso,M. and Brown,S.D. (1996) Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm. Genome, 7, 533-535.
15. Carrel,L. and Willard,H.F. (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400-404.
16. Coy,J.F., Sedlacek,Z., Bachner,D., Delius,H. and Poustka,A. (1999) A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3″-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet., 8, 1253-1262.
17. Pelka,G.J., Watson,C.M., Christodoulou,J. and Tam,P.P. (2005) Distinct expression profiles of Mecp2 transcripts with different lengths of 3'UTR in the brain and visceral organs during mouse development. Genomics 85, 441-452.
18. Lewis,J.D., Meehan,R.R., Henzel,W.J., Maurer-Fogy,I., Jeppesen,P., Klein,F. and Bird,A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69, 905-914.
19. Meehan,R.R., Lewis,J.D. and Bird,A.P. (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res., 20, 5085-5092.
20. Nan,X., Meehan,R.R. and Bird,A. (1993) Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21, 4886-4892.
21. Hendrich,B., Abbott,C., McQueen,H., Chambers,D., Cross,S. and Bird,A. (1999) Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm. Genome, 10, 906-912.
22. Roloff, T.C., Ropers,H.H. and Nuber, U.A. (2003) Comparative study of methyl-CpG-binding domain proteins. BMC Genomics, 4, 1.
23. Klose,R.J., Sarraf,S.A., Schmiedeberg,L., McDermott,S.M., Stancheva,I. and Bird,A.P. (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell, 19, 667-678.
24. Bird,A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
25. Nan,X., Tate,P., Li,E. and Bird,A. (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol., 16, 414-421.
26. Nan,X., Campoy,F.J. and Bird,A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88, 471-481.
27. Nan,X., Ng,H.H., Johnson,C.A., Laherty,C.D., Turner,B.M., Eisenman,R.N. and Bird,A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
28. Jones,P.L., Veenstra,G.J., Wade,P.A., Vermaak,D., Kass,S.U., Landsberger,N., Strouboulis,J. and Wolffe,A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
29. Kokura,K., Kaul,S.C., Wadhwa,R., Nomura,T., Khan,M.M., Shinagawa,T., Yasukawa,T., Colmenares,C. and Ishii,S. (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J. Biol. Chem., 276, 34115-34121.
30. Kaludov,N.K. and Wolffe,A.P. (2000) MeCP2 driven transcriptional repression in vitro: Selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res., 28, 1921-1928.
31. Fuks,F., Hurd,P.J., Wolf,D., Nan,X., Bird,A.P. and Kouzarides,T. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem., 278, 4035-4040.
32. Harikrishnan,K.N., Chow,M.Z., Baker,E.K., Pal,S., Bassal,S., Brasacchio,D., Wang,L., Craig,J.M., Jones,P.L., Sif,S. et al. (2005) Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat. Genet., 37, 254-264.
33. Nan,X., Hou,J., Maclean,A., Nasir,J., Lafuente,M.J., Shu,X., Kriaucionis,S. and Bird,A. (2007) Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci. USA, 104, 2709-2714.
34. Ishibashi,T., Thambirajah,A.A. and Ausio,J. (2008) MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation. FEBS Lett., 582, 1157-1162.
35. Georgel,P.T., Horowitz-Scherer,R.A., Adkins,N., Woodcock,C.L., Wade,P.A. and Hansen,J.C. (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem., 278, 32181-32188.
36. Nikitina,T., Shi,X., Ghosh,R.P., Horowitz-Scherer,R.A., Hansen,J.C. and Woodcock,C.L. (2007) Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell Biol. 27, 864-877.
37. Nikitina,T., Ghosh,R.P., Horowitz-Scherer,R.A., Hansen,J.C., Grigoryev,S.A. and Woodcock,C.L. (2007) MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem., 282, 28237-28245.
38. Galvao,T.C. and Thomas,J.O. (2005) Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain. Nucleic Acids Res., 33, 6603-6609.
39. Kumar,A., Kamboj,S., Malone,B.M., Kudo,S., Twiss,J.L., Czymmek,K.J., LaSalle,J.M. and Schanen,N.C. (2008) Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J. Cell Sci., 121, 1128-1137.
40. Horike,S., Cai,S., Miyano,M., Cheng,J.F. and Kohwi-Shigematsu,T. (2005) Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet., 37, 31-40.
41. Schule,B., Li,H.H., Fisch-Kohl,C., Purmann,C. and Francke,U. (2007) DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 defficiency. Am. J. Hum. Genet., 81, 492-506.
42. Yasui,D.H., Peddada,S., Bieda,M.C., Vallero,R.O., Hogart,A., Nagarajan,R.P., Thatcher,K.N., Farnham,P.J. and Lasalle,J.M. (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA 104, 19416-19421.
43. Chahrour,M., Jung,S.Y., Shaw,C., Zhou,X., Wong,S.T., Qin,J. and Zoghbi,H.Y. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320, 1224-1229.
44. Jeffery,L. and Nakielny,S. (2004) Components of the DNA methylation system of chromatin control are RNA-binding proteins. J. Biol. Chem. 279, 49479-49487.
45. Young,J.I., Hong,E.P., Castle,J.C., Crespo-Barreto,J., Bowman,A.B., Rose,M.F., Kang,D., Richman,R., Johnson,J.M., Berget,S. et al. (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA, 102, 17551-17558.
46. Adams,V.H., McBryant,S.J., Wade,P.A., Woodcock,C.L. and Hansen,J.C. (2007) Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J. Biol. Chem., 282, 15057-15064.
47. Christodoulou,J. (Updated 25 January 2008) MECP2-Related disorders. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online) Copyright, University of Washington, Seattle. 1993-2008. Available at: http://www.genetests.org (7 February 2008, data last accessed).
48. Samaco,R.C., Nagarajan,R.P., Braunschweig,D. and LaSalle,J.M. (2004) Multiple pathways regulate MeCP2 expression in nomal brain development and exhibit defects in autism spectrum disorders. Hum. Mol. Genet. 13, 629-636.
49. Nagarajan,R.P., Hogart,A.R., Gwye,Y., Martin,M.R. and LaSalle,J.M. (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics, 1, e1-e11.
50. Collins,A.L., Levenson,J.M., Vilaythong,A.P., Richman,R., Armstrong,D.L., Noebels,J.L., David Sweatt,J. and Zoghbi,H.Y. (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet., 13, 2679-2689.
51. Friez,M.J., Jones,J.R., Clarkson,K., Lubs,H., Abuelo,D., Bier,J.A., Pai,S., Simensen,R., Williams,C., Giampietro,P.F. et al. (2006) Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics, 118, e1687-e1695.
52. Smrt,R.D., Eaves-Egenes,J., Barkho,B.Z., Santistevan,N.J., Zhao,C., Aimone,J.B., Gage,F.H. and Zhao,X. (2007) Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol. Dis., 27, 77-89.
53. Pelka,G.J., Watson,C.M., Radziewic,T., Hayward,M., Lahooti,H., Christodoulou,J. and Tam,P.P. (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain, 129, 887-898.
54. Chang,Q., Khare,G., Dani,V., Nelson,S. and Jaenisch,R. (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron, 49, 341-348.
55. Chen,W.G., Chang,Q., Lin,Y., Meissner,A., West,A.E., Griffith,E.C., Jaenisch,R. and Greenberg,M.E. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302, 885-889.
56. Stancheva,I., Collins,A.L., Van den Veyver,I.B., Zoghbi,H. and Meehan,R.R. (2003) A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell, 12, 425-435.
57. Kishi,N. and Macklis,J.D. (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci., 27, 306-321.
58. Mnatzakanian,G.N., Lohi,H., Munteanu,I., Alfred,S.E., Yamada,T., MacLeod,P.J., Jones,J.R., Scherer,S.W., Schanen,N.C., Friez,M.J. et al. (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet., 36, 339-341.
59. Kriaucionis,S. and Bird,A. (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res., 32, 1818-1823.
60. Saxena,A., de Lagarde,D., Leonard,H., Williamson,S.L., Vasudevan,V., Christodoulou,J., Thompson,E., MacLeod,P. and Ravine,D. (2006) Lost in translation: Translational interference from a recurrent mutation in exon 1 of MECP2. J. Med. Genet., 43, 470-477.
61. Dragich,J.M., Kim,Y.H., Arnold,A.P. and Schanen,N.C. (2007) Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J. Comp. Neurol., 501, 526-542.
62. Agarwal,N., Hardt,T., Brero,A., Nowak,D., Rothbauer,U., Becker,A., Leonhardt,H. and Cardoso,M.C. (2007) MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res., 35, 5402-5408.
63. Kimura,H. and Shiota,K. (2003) Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem., 278, 4806-4812.
64. Kudo,S. (1998) Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol. Cell. Biol., 18, 5492-5499.
65. Chandler,S.P., Guschin,D., Landsberger,N. and Wolffe,A.P. (1999) The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry, 38, 7008-7018.
66. Buschdorf,J.P. and Stratling,W.H. (2004) A WW domain binding region in methyl-CpG-binding protein MeCP2: Impact on Rett syndrome. J. Mol. Med., 82, 135-143.
67. Sudol,M., Chen,H.I., Bougeret,C., Einbond,A. and Bork,P. (1995) Characterization of a novel protein-binding module-the WW domain. FEBS Lett., 369, 67-71.
68. Pires,J.R., Parthier,C., Aido-Machado,R., Wiedemann,U., Otte,L., Bohm,G., Rudolph,R. and Oschkinat,H. (2005) Structural basis for APPTPPPLPP peptide recognition by the FBP11WW1 domain. J. Mol. Biol. 348, 399-408.
69. Shahbazian,M.D., Antalffy,B., Armstrong,D.L. and Zoghbi,H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
70. Samaco,R.C., Nagarajan,R.P., Braunschweig,D. and LaSalle,J.M. (2004) Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet. 13, 629-639.
71. Balmer,D., Goldstine,J., Rao,Y.M. and LaSalle,J.M. (2003) Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med., 81, 61-68.
72. Kishi,N. and Macklis,J.D. (2005) Dissecting MECP2 function in the central nervous system. J. Child Neurol., 20, 753-759.
73. Guy,J., Gan,J., Selfridge,J., Cobb,S. and Bird,A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315, 1143-1147.
74. Liu,J. and Francke,U. (2006) Identi.cation of cis-regulatory elements for MECP2 expression. Hum. Mol. Genet., 15, 1769-1782.
75. Carninci,P., Sandelin,A., Lenhard,B., Katayama,S., Shimokawa,K., Ponjavic,J., Semple,C.A., Taylor,M.S., Engstrom,P.G., Frith,M.C. et al. (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat. Genet., 38, 626-635.
76. Sandelin,A., Carninci,P., Lenhard,B., Ponjavic,J., Hayashizaki,Y. and Hume,D.A. (2007) Mammalian RNA polymerase II core promoters: Insights from genome-wide studies. Nat. Rev. Genet., 8, 424-436.
77. Koch,C.M., Andrews,R.M., Flicek,P., Dillon,S.C., Karaoz,U., Clelland,G.K., Wilcox,S., Beare,D.M., Fowler,J.C., Couttet,P. et al. (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res., 17, 691-707.
78. Decker,C.J. and Parker,R. (1995) Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell. Biol., 7, 386-392.
79. Margulies,E.H., Cooper,G.M., Asimenos,G., Thomas,D.J., Dewey,C.N., Siepel,A., Birney,E., Keefe,D., Schwartz,A.S., Hou,M. et al. (2007) Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome. Genome Res., 17, 760-774.
80. Brown,T.A. (2007) Genomes 3, 3rd edn. Garland Science, New York.
81. Chen,C.Y. and Shyu,A.B. (1995) AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem. Sci., 20, 465-470.
82. Klein,M.E., Lioy,D.T., Ma,L., Impey,S., Mandel,G. and Goodman,R.H. (2007) Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci., 10, 1513-1514.
83. Denoeud,F., Kapranov,P., Ucla,C., Frankish,A., Castelo,R., Drenkow,J., Lagarde,J., Alioto,T., Manzano,C., Chrast,J. et al. (2007) Prominent use of distal 5′ transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res., 17, 746-759.
84. Okazaki,Y., Furuno,M., Kasukawa,T., Adachi,J., Bono,H., Kondo,S., Nikaido,I., Osato,N., Saito,R., Suzuki,H. et al. (2002) Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature, 420, 563-573.
85. Mercer,T.R., Dinger,M.E., Sunkin,S.M., Mehler,M.F. and Mattick,J.S. (2008) Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl Acad. Sci. USA, 105, 716-721.
86. Perez,D.S., Hoage,T.R., Pritchett,J.R., Ducharme-Smith,A.L., Halling,M.L., Ganapathiraju,S.C., Streng,P.S. and Smith,D.I. (2008) Long, abundantly expressed non-coding transcripts are altered in cancer. Hum. Mol. Genet., 17, 642-655.
87. Ravasi,T., Suzuki,H., Pang,K.C., Katayama,S., Furuno,M., Okunishi,R., Fukuda,S., Ru,K., Frith,M.C., Gongora,M.M. et al. (2006) Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res., 16, 11-19.
88. Sasaki,Y.T., Sano,M., Ideue,T., Kin,T., Asai,K. and Hirose,T. (2007) Identification and characterization of human non-coding RNAs with tissue-specific expression. Biochem. Biophys. Res. Commun., 357 991-996.
89. Kim,T.H., Abdullaev,Z.K., Smith,A.D., Ching,K.A., Loukinov,D.I., Green,R.D., Zhang,M.Q., Lobanenkov,V.V. and Ren,B. (2007) Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell, 128, 1231-1245.
90. Martinowich,K., Hattori,D., Wu,H., Fouse,S., He,F., Hu,Y., Fan,G. and Sun,Y.E. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science, 302, 890-893.
91. Ballestar,E., Ropero,S., Alaminos,M., Armstrong,J., Setien,F., Agrelo,R., Fraga,M.F., Herranz,M., Avila,S., Pineda,M. et al. (2005) The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum. Genet., 116, 91-104.
92. Samaco,R.C., Hogart,A. and LaSalle,J.M. (2005) Epigenetic over-lap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet., 14 483-492.
93. Makedonski,K., Abuhatzira,L., Kaufman,Y., Razin,A. and Shemer,R. (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet., 14, 1049-1058.
94. Nuber,U.A., Kriaucionis,S., Rolo.,T.C., Guy,J., Selfridge,J., Steinhoff,C., Schulz,R., Lipkowitz,B., Ropers,H.H., Holmes,M.C. et al. (2005) Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum. Mol. Genet., 14, 2247-2256.
95. Peddada,S., Yasui,D.H. and LaSalle,J.M. (2006) Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum. Mol. Genet., 15 2003-2014.
96. McGill,B.E., Bundle,S.F., Yaylaoglu,M.B., Carson,J.P., Thaller,C. and Zoghbi,H.Y. (2006) Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA, 103, 18267-18272.
97. Itoh,M., Ide,S., Takashima,S., Kudo,S., Nomura,Y., Segawa,M., Kubota,T., Mori,H., Tanaka,S., Horie,H. et al. (2007) Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J. Neuropathol. Exp. Neurol., 66, 117-123.
98. Deng,V., Matagne,V., Banine,F., Frerking,M., Ohliger,P., Budden,S., Pevsner,J., Dissen,G.A., Sherman,L.S. and Ojeda,S.R. (2007) FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet., 16, 640-650.
99. Jordan,C., Li,H.H., Kwan,H.C. and Francke,U. (2007) Cerebellar gene expression pro.les of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet., 8, 36.
100. Jordan,C. and Francke,U. (2006) Ube3a expression is not altered in Mecp2 mutant mice. Hum. Mol. Genet., 15, 2210-2215.